Umbilical cord blood as a source for red-blood-cell transfusion in neonatology: a systematic review

Research output: Contribution to journalReview articlepeer-review

Abstract

The prevention and treatment of anaemia in newborn patients made tremendous progress in the last decades. However, red-blood-cell (RBC) transfusions remain unavoidable in many neonates candidate to surgery and especially in preterm infants. In particular, anaemia occurring in neonates born at extremely low gestational age is actually severe and frequently requires transfusions. Several approaches have been explored to prevent or even to reduce the threshold and the frequency of RBC transfusions. Among these, umbilical cord blood (UCB) collection and processing to obtain RBC components for autologous or allogeneic transfusion have been extensively investigated. In this systematic review, we revised the literature concerning the use of UCB for either autologous or allogeneic transfusion purposes and we illustrated the rationale for a transfusion therapy tailored to extremely preterm neonates, based on RBC concentrates from allogeneic UCB donations.

Original languageEnglish
Pages (from-to)713-725
Number of pages13
JournalVox Sanguinis
Volume113
Issue number8
DOIs
Publication statusPublished - Nov 1 2018

Keywords

  • cord blood
  • individualized therapy
  • premature birth
  • transfusion

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Umbilical cord blood as a source for red-blood-cell transfusion in neonatology: a systematic review'. Together they form a unique fingerprint.

Cite this